Pliant Therapeutics, Inc. SEC filings PLRX
Pliant Therapeutics, Inc. has 438 filings in SEC EDGAR's recent list, going back to Jul 20, 2018. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 11, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Aug 11, 2026 | Aug 11, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 13, 2026 | Jul 9, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 11, 2026 | Jun 11, 2026 |
| 8-K |
Current report
Results of operations
|
May 11, 2026 | May 11, 2026 |
| 8-K |
Current report
Officer or director change
|
Apr 17, 2026 | Apr 14, 2026 |
| 8-K |
Current report
Other events
|
Mar 30, 2026 | Mar 27, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 11, 2026 | Mar 11, 2026 |
| 8-K |
Current report
Material agreement, Change to shareholder rights
|
Mar 3, 2026 | Mar 3, 2026 |
| 8-K |
Current report
Officer or director change
|
Dec 16, 2025 | Dec 10, 2025 |
| 8-K |
Current report
Officer or director change
|
Dec 8, 2025 | Dec 2, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Officer or director change
|
Oct 24, 2025 | Oct 20, 2025 |
| 8-K |
Current report
Agreement ended
|
Oct 20, 2025 | Oct 14, 2025 |
| 8-K | Current report | Aug 7, 2025 | Aug 7, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 9, 2025 | Jun 5, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| 8-K |
Current report
Exit or restructuring costs, Officer or director change
|
May 1, 2025 | May 1, 2025 |
| 8-K |
Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Mar 13, 2025 | Mar 12, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 3, 2025 | Mar 3, 2025 |
| 8-K |
Current report
Other events
|
Feb 13, 2025 | Feb 13, 2025 |
| 8-K |
Current report
Other events
|
Feb 10, 2025 | Feb 7, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Sep 27, 2024 | Sep 24, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2024 | Aug 7, 2024 |
| 8-K |
Current report
Other events
|
Jul 15, 2024 | Jul 15, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 14, 2024 | Jun 13, 2024 |
| 8-K |
Current report
Other events
|
May 14, 2024 | May 14, 2024 |
| 8-K |
Current report
Results of operations
|
May 6, 2024 | May 6, 2024 |
| 8-K |
Current report
Material agreement, New debt, Other events
|
Mar 12, 2024 | Mar 11, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 27, 2024 | Feb 27, 2024 |
| 8-K |
Current report
Other events
|
Feb 5, 2024 | Feb 4, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2023 | Nov 9, 2023 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt
|
Oct 3, 2023 | Sep 28, 2023 |
| 8-K |
Current report
Other events
|
Sep 26, 2023 | Sep 26, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2023 | Aug 9, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 8, 2023 | Jun 7, 2023 |
| 8-K |
Current report
Results of operations
|
May 9, 2023 | May 9, 2023 |
| 8-K |
Current report
Other events
|
May 1, 2023 | Apr 30, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 9, 2023 | Mar 9, 2023 |
| 8-K |
Current report
Officer or director change
|
Mar 8, 2023 | Mar 6, 2023 |
| 8-K |
Current report
Agreement ended
|
Feb 23, 2023 | Feb 17, 2023 |
| 8-K |
Current report
Results of operations, Other events
|
Jan 25, 2023 | Jan 23, 2023 |
| 8-K |
Current report
Other events
|
Jan 23, 2023 | Jan 23, 2023 |
| 8-K |
Current report
Other events
|
Jan 23, 2023 | Jan 22, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 9, 2023 | Jan 9, 2023 |
| 8-K |
Current report
Officer or director change
|
Nov 18, 2022 | Nov 16, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2022 | Nov 8, 2022 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change
|
Sep 16, 2022 | Sep 14, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2022 | Aug 8, 2022 |
| 8-K |
Current report
Results of operations, Other events
|
Jul 14, 2022 | Jul 11, 2022 |
| 8-K |
Current report
Other events
|
Jul 11, 2022 | Jul 10, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 17, 2022 | Jun 16, 2022 |
| 8-K |
Current report
Results of operations
|
May 9, 2022 | May 9, 2022 |
| 8-K |
Current report
Material agreement, New debt
|
May 5, 2022 | May 4, 2022 |
| 8-K/A |
Amended current report
Results of operations
|
Mar 1, 2022 | Feb 28, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 28, 2022 | Feb 28, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 10, 2022 | Jan 10, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2021 | Nov 9, 2021 |
| 8-K |
Current report
Other events
|
Sep 7, 2021 | Sep 7, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2021 | Aug 9, 2021 |
| 8-K |
Current report
Officer or director change
|
Jul 2, 2021 | Jun 29, 2021 |
| 8-K |
Current report
Results of operations
|
May 10, 2021 | May 10, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 16, 2021 | Mar 16, 2021 |
| 8-K |
Current report
Officer or director change
|
Jan 13, 2021 | Jan 12, 2021 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Dec 21, 2020 | Dec 15, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2020 | Nov 10, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2020 | Aug 11, 2020 |
Showing 67 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PLRX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- South San Francisco, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1746473
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.